Existing studies have described the abnormal NEC immunophenotypes in patients with MDS, including increased coefficient of variation (CV) of CD36 and CD71 fluorescence intensities and decreased mean fluorescence intensity (MFI) of CD36 and CD717,8. This evidence concerns the gene TFRC and myelodysplastic syndrome.